000 03900nam a22003975i 4500
001 76550
003 ES-MaUEC
005 20230207040229.0
007 cr nn 008mamaa
008 140508s2014 gw s 000 0 eng d
020 _a9783642538339
024 7 _a10.1007/978-3-642-53833-9
_2doi
040 _aES-MaUEC
050 4 _aQR46
_b.A58 2014 EB
082 0 4 _a579
245 0 0 _aAntibiofilm Agents :
_bFrom Diagnosis to Treatment and Prevention
_cedited by Kendra P. Rumbaugh, Iqbal Ahmad
264 1 _aBerlin, Heidelberg
_bSpringer International Publishing
_c2014
300 _a1 recurso en línea (IX, 497 p.)
_b80 ilustraciones, 35 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 1 _aSpringer Series on Biofilms
_x1863-9607
_v8
505 0 _aPart I: Medical Biofilms -- Biofilms in Disease -- The Use of DNA Methods to Characterize Biofilm Infection -- Imaging Biofilms in Tissue Specimens -- Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms -- Horizontal Gene Transfer in Planktonic and Biofilm Modes -- The Role of Quorum Sensing in Biofilm Development -- Part II: Strategies for Biofilm Control -- Current and Emergent Control Strategies for Medical Biofilms -- The Effect of Plasmids and Other Biomolecules on the Effectiveness of Antibiofilm Agents -- Antimicrobial Coatings to Prevent Biofilm Formation on Medical Devices -- Medicinal Plants and Phytocompounds: A Potential Source of Novel Antibiofilm Agents -- Staphylococcus Aureus Biofilm Formation and Inhibition -- Novel Targets for Treatment Of Pseudomonas Aeruginosa Biofilms -- Inhibition of Fungal Biofilms -- Biofilm Control Strategies in Dental Health -- Inhibition of Polymicrobial Biofilms: Recent Trends -- Antibiofilm Strategies in the Food Industry -- Part III: The Future of Antibiofilm Agents -- Biofilm Inhibition by Nanoparticles -- Drug Delivery Systems That Eradicate and/or Prevent Biofilm Formation -- Eradication of Wound Biofilms by Electrical Stimulation -- The Effects of Photodynamic Therapy in Oral Biofilms -- Clinical and Regulatory Development of Antibiofilm Drugs: The Need, The Potential and The Challenges
520 3 _aThis book provides a survey of recent advances in the development of antibiofilm agents for clinical and environmental applications. The fact that microbes exist in structured communities called biofilms has slowly become accepted within the medical community. We now know that over 80% of all infectious diseases are biofilm-related; however, significant challenges still lie in our ability to diagnose and treat these extremely recalcitrant infections. Written by experts from around the globe, this book offers a valuable resource for medical professionals seeking to treat biofilm-related disease, academic and industry researchers interested in drug discovery, and instructors who teach courses on microbial pathogenesis and medical microbiology
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGERrevisando
650 7 _9405049
_aMicrobiología médica
_0comprobar BNE19900963008
_2embne
650 7 _aEnfermedades infecciosas
_0comprobar BNE19900959429
_2embne
_9138404
700 1 _aRumbaugh, Kendra P.
_0nb2010032094
_eeditor literario
_948578
700 1 _aAhmad, Iqbal
_dLecturer in agricultural microbiology
_0n 2006094974
_eeditor literario
_948579
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-53833-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783642538339
907 _a.b12821688
_b07-11-17
_c01-10-14
998 _am
_a_alco
_a_vill
_b06-11-17
_cm
_dz
_eu
_feng
_ggw
_h0
945 _aQR46 .A58 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11550892
_z06-04-17
999 _c76550
_d76550
_x1